2.4 semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial Wegovy was approved by the Food and Drug Administration (FDA) in 2021 and is marketed by Novo Nordisk How Many Units Is 2.4
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19



























